300 years on from the original Longitude Prize, we’ve launched a new prize for a new century.
300 years on from the original Longitude Prize, we launched a new prize for a new century, and the British public chose Antibiotics to be the focus of Longitude Prize.
The challenge is to create a cost-effective, accurate, rapid, and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time.
Now that the challenge has been chosen, we want everyone, from amateur scientists to the professional scientific community, to try and solve it.
How did you choose the six challenges?
The Longitude Committee led by Astronomer Royal Lord Martin Rees, started in summer 2013 by convening a roundtable consultation with over 40 of the country’s leading scientists, engineers, and politicians at 10 Downing Street. Ideas were discussed under the broad themes of:
- global development
- technology and robotics
- democratising access to communications
- health and wellbeing
Under these themes the group identified a number of global challenges suitable for Longitude Prize.
These initial challenge areas were subjected to multiple rounds of critical analysis and deliberation, working with over 100 scientists, academics and the public to review, question and comment on them.
Co-funded by Sciencewise, the UK’s national centre for public dialogue in policy making involving science and technology issues, we commissioned IPSOS Mori to hold six public dialogue workshops across the country and one workshop with public and private stakeholders. We presented the findings along with the final list of proposed areas to the Longitude Committee.
The Longitude Committee shortlisted six challenges and the Great British public had the opportunity to vote for the one they thought should become the focus of Longitude Prize.
Voting took place between 22 May and 25 June and the winning challenge was announced on 25 June 2014.
Enter the Prize
The Longitude Prize is a £10m prize fund that will reward a competitor that can develop a point–of–care diagnostic test that will conserve antibiotics for future generations and revolutionise the delivery of global healthcare. The test must be accurate, rapid, affordable and easy to use anywhere in the world.